Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2025Emergency Care and MedicineOpen Access

From the Emergency Department to Follow-Up: Clinical Utility of Biomarkers in Mild Traumatic Brain Injury

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGiacomo SpazianiGRGloria RozziSBSilvia Baroni

Discussion

Loading...

Member takes

Overview

This analysis reveals biomarkers like GFAP and UCH-L1 improve sensitivity for mTBI diagnostics, suggesting their clinical value.

Key Points

  • The study finds that biomarkers like GFAP and UCH-L1 enhance diagnostic sensitivity for mTBI.
  • High sensitivity of GFAP and UCH-L1 suggests effectiveness in detecting intracranial lesions within 12 hours post-injury.
  • Biomarker analysis employs metrics including sensitivity, specificity, and area under the curve to assess performance.
  • Incorporating these biomarkers into clinical practice may lead to more precise mTBI management and reduced imaging reliance.

Cite This Study

Spaziani et al. (2025) studied this question.

synapsesocial.com/papers/68d41ee7713b0b5dfea6837dhttps://doi.org/10.3390/ecm2030045
View Full Paper
Ask AI
Bookmark
Share